Caldwell Trust
BMY icon

Caldwell Trust’s Bristol-Myers Squibb BMY Stock Holding History

Caldwell Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.88M Sell
30,077
-112
-0.4% -$7.08K 0.15% 118
2026
Q2 		$1.74M Sell
30,189
-2,960
-9% -$170K 0.14% 126
2026
Q1 		$2.01M Sell
33,149
-435
-1% -$25.4K 0.18% 108
2025
Q4 		$1.81M Sell
33,584
-1,587
-5% -$76.3K 0.16% 110
2025
Q3 		$1.59M Sell
35,171
-1,458
-4% -$68.1K 0.15% 127
2025
Q2 		$1.7M Sell
36,629
-1,209
-3% -$59.3K 0.17% 117
2025
Q1 		$2.31M Buy
37,838
+135
+0.4% +$7.87K 0.25% 90
2024
Q4 		$2.13M Sell
37,703
-1,264
-3% -$70.6K 0.22% 94
2024
Q3 		$2.02M Sell
38,967
-1,431
-4% -$67.1K 0.21% 99
2024
Q2 		$1.68M Sell
40,398
-740
-2% -$33.1K 0.19% 107
2024
Q1 		$2.23M Sell
41,138
-2,212
-5% -$113K 0.26% 84
2023
Q4 		$2.22M Sell
43,350
-2,843
-6% -$149K 0.28% 79
2023
Q3 		$2.68M Sell
46,193
-2,841
-6% -$174K 0.37% 64
2023
Q2 		$3.14M Sell
49,034
-1,182
-2% -$79.3K 0.41% 55
2023
Q1 		$3.48M Sell
50,216
-1,158
-2% -$81.7K 0.48% 49
2022
Q4 		$3.7M Buy
51,374
+382
+0.7% +$28.8K 0.52% 51
2022
Q3 		$3.63M Sell
50,992
-1,209
-2% -$87.7K 0.54% 46
2022
Q2 		$4.02M Buy
52,201
+3,532
+7% +$269K 0.55% 47
2022
Q1 		$3.55M Sell
48,669
-578
-1% -$38.8K 0.42% 58
2021
Q4 		$3.07M Sell
49,247
-950
-2% -$55.7K 0.35% 65
2021
Q3 		$2.97M Sell
50,197
-2,962
-6% -$195K 0.38% 63
2021
Q2 		$3.55M Sell
53,159
-1,306
-2% -$85.2K 0.46% 52
2021
Q1 		$3.44M Sell
54,465
-562
-1% -$35K 0.48% 50
2020
Q4 		$3.41M Sell
55,027
-6,406
-10% -$394K 0.52% 50
2020
Q3 		$3.7M Sell
61,433
-4,315
-7% -$260K 0.61% 46
2020
Q2 		$3.87M Buy
65,748
+12
+0% +$718 0.65% 45
2020
Q1 		$3.66M Sell
65,736
-2,120
-3% -$130K 0.69% 44
2019
Q4 		$4.36M Buy
+67,856
New +$3.89M 0.67% 48

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Caldwell Trust's BMY Position: Q3 2026 in Review

Caldwell Trust reduced its Bristol-Myers Squibb (BMY) stake by 0.37% in Q3 2026, selling an estimated $7.08K and leaving 30,077 shares worth $1.88M. The position accounts for 0.15% of the portfolio, ranked #118.

Caldwell Trust first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $4.36M in Q4 2019. 1,630 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Caldwell Trust held 30,077 shares of Bristol-Myers Squibb worth $1.88M as of Q3 2026.
  • Caldwell Trust sold 112 Bristol-Myers Squibb shares in Q3 2026, an estimated $7.08K.
  • Bristol-Myers Squibb made up 0.15% of Caldwell Trust's portfolio in Q3 2026, its #118 holding.
  • Caldwell Trust first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
  • Caldwell Trust's Bristol-Myers Squibb position peaked at $4.36M in Q4 2019.
  • 1,630 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.